Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
08 mars 2018 16h05 HE
|
Codexis, Inc.
2017 revenues of $50 million include a 74% increase in product salesIntroduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available...
Leading Doctor with Enzymedica Addresses Difference Between Digestive Enzymes and Probiotics to Improve Gut Health
01 mars 2018 16h37 HE
|
Enzymedica
VENICE, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- There are trillions of organisms in the human digestive tract that affect what, how and even when we should eat. Of these microbes, some are helpful,...
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
01 mars 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial...
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
15 févr. 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position...
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
12 févr. 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the...
Codexis to Present at Two Investment Conferences in November
09 nov. 2017 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in...
Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
12 oct. 2017 08h00 HE
|
Codexis, Inc.
Includes an option for the global development of CDX-6114 for PKU, marking Codexis’ first partnership for an internally developed biotherapeutic product. Codexis receives an upfront payment of $14...
Codexis Reports Financial Results for the Second Quarter of 2017
09 août 2017 16h05 HE
|
Codexis, Inc.
Product sales more than doubled versus prior-year second quarter Affirms 2017 total revenue guidance; increases full year product sales and gross margin guidance Conference call begins at 4:30 pm...
Codexis to Hold 2017 Second Quarter Conference Call on August 9
02 août 2017 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report second quarter 2017 financial results after...
Animal Feed Additives Market worth over USD 22 Billion by 2022: Global Market Insights, Inc.
18 juil. 2017 07h30 HE
|
Global Market Insights, Inc
Ocean View, Delaware, July 18, 2017 (GLOBE NEWSWIRE) -- The Industry Outlook report “Animal Feed Additives Market By Livestock (Poultry, Aquaculture, Pork/Swine, Cattle), By Product (Vitamins,...